A comprehensive analysis of lung cancer samples from TCGA revealed that upregulation of PHF23 increased the 50% inhibitory concentration (IC50) of cisplatin and docetaxel, two commonly used drugs for chemotherapy in NSCLC (Fig. 3A). The gene discussed is PHF23; the disease is non-small cell lung carcinoma.